JT

Juste Tyle

Global Commercial Director for Factor XIa inhibitor

Juste Tyle is a business manager with a deep background in finance and a proven track record in sales development. They served as a Junior Finance Analyst at Eurovaistine from 2007 to 2008 and later as a Finance Analyst at Euroapotheca, UAB until 2010. Juste held various positions at Bayer Pharmaceuticals from 2019 to 2023, including Commercial Lead Global Hemophilia, showcasing expertise in technical innovation and sales strategy. They developed a key cardiology product that became the No. 1/2 prescription product in Lithuania, demonstrating a strong commitment to innovation and team empowerment. Juste earned a Master’s degree in Financial Economics from ISM Graduate School in 2010.

Location

Basel, Switzerland

Links


Org chart

This person is not in the org chart


Teams

This person is not in any teams


Offices

This person is not in any offices